Skip to main content
SpringerLink
Log in

Endoscopy and Endoscopic Ultrasound Examination of the Stomach

  • Chapter
  • First Online:
Gastric Cancer

  • 2620 Accesses

Abstract

As the fifth most frequently diagnosed cancer worldwide, and the third most common cause of cancer-related deaths, gastric cancer represents a significant cause of global morbidity and mortality. Gastrointestinal endoscopy plays an integral role in the screening, surveillance, diagnosis, and staging of gastric cancer. This chapter reviews the most recent evidence-based clinical and endoscopic practice for adenocarcinoma of the stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

H. pylori :

Helicobacter pylori

UGI:

Upper gastrointestinal

WLE:

White light endoscopy

OLGA:

Operative link of gastritis assessment

OLGIM:

Operative link of gastric intestinal metaplasia

ASGE:

American Society of Gastrointestinal Endoscopy

HDGC:

Hereditary diffuse gastric cancer

PJS:

Peutz-Jeghers syndrome

JPS:

Juvenile polyposis syndrome

FAP:

Familial adenomatous polyposis

HNPCC:

Hereditary nonpolyposis colorectal cancer

FGP:

Fundic gland polyp

EMR:

Endoscopic mucosal resection

ESD:

Endoscopic submucosal dissection

NBI:

Narrow band imaging

M-NBI:

Magnification NBI

HER2:

Human epidermal growth factor receptor 2

ASA:

American Society of Anesthesiologists

EUS:

Endoscopic ultrasound

FNA:

Fine needle aspiration

MDCT:

Multidetector computed tomography

MRI:

Magnetic resonance imaging

FJP:

Familial juvenile polyposis

References

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. http://globocan.iarc.fr. Accessed 22 July 2014.

  2. Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12(1):135–8.

    Article  CAS  PubMed  Google Scholar 

  3. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38(4):259–67.

    Article  PubMed  Google Scholar 

  4. Tsubono Y, Nishino Y, Tsuji I, Hisamichi S. Screening for gastric cancer in Miyagi, Japan: evaluation with a Population-Based Cancer Registry. Asian Pac J Cancer Prev. 2000;1(1):57–60.

    PubMed  Google Scholar 

  5. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132(6):1272–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Cho E, Kang MH, Choi KS, Suh M, Jun JK, Park EC. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Asian Pac J Cancer Prev. 2013;14(4):2533–40.

    Article  PubMed  Google Scholar 

  7. Choi KS, Jun JK, Park EC, Park S, Jung KW, Han MA, Choi IJ, Lee HY. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One. 2012;7(11):e50041. doi:10.1371/journal.pone.0050041. (Epub 2012 Nov 29).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Areia M, Carvalho R, Cadime AT, Rocha Gonçalves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter. 2013;18(5):325–37.

    Article  PubMed  Google Scholar 

  9. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  10. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42(2):211–7.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.

    Article  PubMed  Google Scholar 

  13. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134(4):945–52.

    Article  PubMed  Google Scholar 

  14. Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2014;26(4):378–87.

    Article  PubMed  Google Scholar 

  15. Areia M, Amaro P, Dinis-Ribeiro M, Cipriano MA, et al. External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions. Gastrointest Endosc. 2008;67(7):1011–8.

    Article  PubMed  Google Scholar 

  16. Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol. 2011;26(Suppl 1):31–4.

    Article  PubMed  Google Scholar 

  17. Eshmuratov A, Nah JC, Kim N, Lee HS, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55(5):1364–75.

    Article  PubMed  Google Scholar 

  18. Lim JH, Kim N, Lee HS, Choe G, et al. Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia. Gut Liver. 2013;7(1):41–50.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 2013;27(2):205–23.

    Article  PubMed  Google Scholar 

  20. Vannella L, Lahner E, Osborn J, Bordi C, Miglione M, Delle Fave G, Annibale B. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31(9):1042–50.

    CAS  PubMed  Google Scholar 

  21. O’Connor A, McNamara D, O'Moráin CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9:CD009322. doi:10.1002/14651858.CD009322.pub2.

    Google Scholar 

  22. You WC, Li JY, Blot WJ, Chang YS, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999;83(5):615–9.

    Article  CAS  PubMed  Google Scholar 

  23. Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC, Chung JB. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(8):620–6.

    Article  CAS  PubMed  Google Scholar 

  24. Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37(4):375–82.

    Article  CAS  PubMed  Google Scholar 

  25. Pharoah PD, Guilford P, Caldas C. International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001;121(6):1348–53.

    Article  CAS  PubMed  Google Scholar 

  26. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54:3845–52.

    CAS  PubMed  Google Scholar 

  27. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, International Gastric Cancer Linkage Consortium, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119(6):1447–53.

    Article  CAS  PubMed  Google Scholar 

  29. van Lier MG, Wagner A, Mathus-Vliegen EM, et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010;105:1258–64.

    Article  PubMed  Google Scholar 

  30. Beggs AD, Latchford AR, Vasen HF, Moslein G, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975–86.

    Article  CAS  PubMed  Google Scholar 

  31. Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012;18(4):355–63.

    Article  CAS  PubMed  Google Scholar 

  32. Vasen HF, Möslein G, Alonso A, Aretz S, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57(5):704–13.

    Article  CAS  PubMed  Google Scholar 

  33. Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):180–5.

    Article  PubMed  Google Scholar 

  34. Ngamruengphong S, Boardman LA, Heigh RI, Krishna M, Roberts ME, Riegert-Johnson DL. Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract. 2014;12(1):4.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Renkonen-Sinisalo L, Sipponen P, Aarnio M. No support for endoscopic surveillance of gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol. 2002;37:574–7.

    Article  CAS  PubMed  Google Scholar 

  36. Park YJ, Shin K, Park J. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res. 2000;6:2994–8.

    CAS  PubMed  Google Scholar 

  37. Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology. 2010;138(2):487–92.

    Article  PubMed  Google Scholar 

  38. Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, et al. Mallorca group. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013; 62(6): 812–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Giardiello FM, Allen JI, Axilbund JE, Boland CR, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-society Task Force on colorectal cancer. Gastrointest Endosc. 2014;80(2):197–220.

    Article  PubMed  Google Scholar 

  40. Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1–27.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.

    Article  Google Scholar 

  42. Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc. 2013;2013:241320. doi:10.1155/2013/241320. (Epub 2013 Feb 28).

    Article  PubMed Central  PubMed  Google Scholar 

  43. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 Suppl):S3–43.

    Google Scholar 

  44. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointest Endosc. 2011;73(5):917–27.

    Article  PubMed  Google Scholar 

  45. Kim JJ, Lee JH, Jung HY, Lee GH, et al. EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc. 2007;66(4):693–700.

    Article  PubMed  Google Scholar 

  46. Sakai Y, Eto R, Kasanuki J, Kondo F, et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest Endosc. 2008;68(4):635–41.

    Article  PubMed  Google Scholar 

  47. Lee BE, Kim GH, Park do Y, Kim DH, et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol. 2010;10:97.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Uedo N, Fujishiro M, Goda K, Hirasawa D, et al. Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in Asia-Pacific region. Dig Endosc. 2011;23(Suppl 1):58–71.

    Article  PubMed  Google Scholar 

  49. Hayee B, Inoue H, Sato H, Santi EG, Yoshida A, Onimaru M, Ikeda H, Kudo SE. Magnification narrow-band imaging for the diagnosis of early gastric cancer: a review of the Japanese literature for the Western endoscopist. Gastrointest Endosc. 2013;78(3):452–61.

    Article  PubMed  Google Scholar 

  50. Uedo N, Ishihara R, Iishi H, Yamamoto S, et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 2006;38(8):819–24.

    Article  CAS  PubMed  Google Scholar 

  51. Fujiwara S, Yao K, Nagahama T, Uchita K, et al. Can we accurately diagnose minute gastric cancers (≤ 5 mm)? Chromoendoscopy (CE) vs magnifying endoscopy with narrow band imaging (M-NBI). Gastric Cancer. 2014 (Jul 9. [Epub ahead of print]).

    Google Scholar 

  52. Ajani JA, Bentrem DJ, Besh S, D’Amico TA, National Comprehensive Cancer Network, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11(5):531–46.

    CAS  PubMed  Google Scholar 

  53. Jeon HK, Ryu HY, Cho MY, Kim HS, et al. A randomized trial to determine the diagnostic accuracy of conventional vs. jumbo forceps biopsy of gastric epithelial neoplasias before endoscopic submucosal dissection; open-label study. Gastric Cancer. 2013 (Dec 13. [Epub ahead of print]).

    Google Scholar 

  54. Fukase K, Kato M, Kikuchi S, Inoue K, Japan Gast Study Group, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392–7.

    Article  PubMed  Google Scholar 

  55. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, ToGA Trial Investigators, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.

    Article  CAS  PubMed  Google Scholar 

  56. Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS, Koh DH. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc. 2010;71(7):1159–65.

    Article  PubMed  Google Scholar 

  57. ASGE Standards of Practice Committee, Ben-Menachem T, Decker GA, Early DS, Evans J, Fanelli RD, Fisher DA, Fisher L, Fukami N, Hwang JH, Ikenberry SO, Jain R, Jue TL, Khan KM, Krinsky ML, Malpas PM, Maple JT, Sharaf RN, Dominitz JA, Cash BD. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76(4):707–18.

    Article  PubMed  Google Scholar 

  58. Parekh PJ. Merrell J1, Clary M1, Brush JE2, Johnson DA3. New anticoagulants and antiplatelet agents: a primer for the clinical gastroenterologist. Am J Gastroenterol. 2014;109(1):9–19.

    Article  CAS  PubMed  Google Scholar 

  59. Chen YI, Barkun AN, Soulellis C, Mayrand S, Ghali P. Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc. 2012;75(6):1278–81.

    Article  PubMed  Google Scholar 

  60. ASGE Standards of Practice Committee, Banerjee S, Shen B, Baron TH, Nelson DB, Anderson MA, Cash BD, Dominitz JA, Gan SI, Harrison ME, Ikenberry SO, Jagannath SB, Lichtenstein D, Fanelli RD, Lee K, van Guilder T, Stewart LE. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67(6):791–8.

    Article  PubMed  Google Scholar 

  61. Shen L, Shan YS, Hu HM, Price TJ, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.

    Article  PubMed  Google Scholar 

  62. Cardoso R, Coburn N, Seevaratnam R, Sutradhar R, Lourenco LG, Mahar A, Law C, Yong E, Tinmouth J. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer. 2012;15(Suppl 1):S19–26.

    Article  PubMed  Google Scholar 

  63. Puli SR, Batapati Krishna Reddy J, Bechtold ML, Antillon MR, Ibdah JA. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol. 2008;14(25):4011–9.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25(15):2107–16.

    Article  PubMed  Google Scholar 

  65. Kim JH, Song KS, Youn YH, Lee YC, Cheon JH, Song SY, Chung JB. Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc. 2007;66(5):901–8.

    Article  PubMed  Google Scholar 

  66. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45(6):474–9.

    Article  CAS  PubMed  Google Scholar 

  67. Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12(1):6–22.

    Article  CAS  PubMed  Google Scholar 

  68. Prasad P, Schmulewitz N, Patel A, Varadarajulu S, et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc. 2004;59(1):49–53.

    Article  PubMed  Google Scholar 

  69. Lee YT, Ng EK, Hung LC, Chung SC, Ching JY, Chan WY, Chu WC, Sung JJ. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut. 2005;54(11):1541–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. DeWitt J, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of ascites. Clin Gastroenterol Hepatol. 2007;5(5):609–15.

    Article  PubMed  Google Scholar 

  71. ASGE Standards of Practice Committee, Early DS, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, Evans JA, Fanelli RD, Fisher DA, Fonkalsrud L, Hwang JH, Jue TL, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf RN, Shergill AK, Cash BD. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc. 2013;77(6):839–43.

    Article  PubMed  Google Scholar 

  72. Wang KX, Ben QW, Jin ZD, Du YQ, Zou DW, Liao Z, Li ZS. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73(2):283–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Nutrition, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10065, New York, NY, USA

    Dr. Mark A. Schattner MD, FACP & Dr. John Chi To Wong MSc, MD

Authors
  1. Dr. Mark A. Schattner MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. John Chi To Wong MSc, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark A. Schattner MD, FACP .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schattner, M., Wong, J. (2015). Endoscopy and Endoscopic Ultrasound Examination of the Stomach. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation